Gilead Sciences
GILD
#94
Rank
HK$1.428 T
Marketcap
HK$1,151
Share price
-1.03%
Change (1 day)
28.16%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): HK$50.82

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is HK$51.03. In 2024 the company made an earnings per share (EPS) of HK$2.97 a decrease over its 2023 EPS that were of HK$35.61.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$50.821608.59%
2024HK$2.97-91.65%
2023HK$35.6123.98%
2022HK$28.72-25.86%
2021HK$38.744850%
2020HK$0.78-97.64%
2019HK$33.190.9%
2018HK$32.8918.71%
2017HK$27.71-64.88%
2016HK$78.89-18.45%
2015HK$96.7455.28%
2014HK$62.30296.02%
2013HK$15.7317.89%
2012HK$13.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.17 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.64-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.72-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.17 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.16 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$86.02 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$34.99-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$112.16 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.19 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA